A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer
Clinical trial NCT07527026 · RECRUITING
Trial details
- NCT number
- NCT07527026
- Sponsor
- Chinese PLA General Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2028-02-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.